share_log

Wells Fargo Downgrades Axonics to Equal-Weight, Raises Price Target to $71

Wells Fargo Downgrades Axonics to Equal-Weight, Raises Price Target to $71

富国银行将Axonics的评级下调至同等权重,将目标股价上调至71美元
Benzinga ·  01/10 06:50

Wells Fargo analyst Larry Biegelsen downgrades Axonics (NASDAQ:AXNX) from Overweight to Equal-Weight and raises the price target from $68 to $71.

富国银行分析师拉里·比格尔森将Axonics(纳斯达克股票代码:AXNX)的评级从增持下调至同等,并将目标股价从68美元上调至71美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发